Pradaxa Problems Are Not Rare
As of June 2014, Saiontz & Kirk is no longer accepting new Pradaxa clients The contents of this page are provided for informational purposes only Although Boehringer Ingelheim, the maker of the new...
View ArticleClass Action Lawsuit for Pradaxa vs MDL
As of June 2014, Saiontz & Kirk is no longer accepting new Pradaxa clients The contents of this page are provided for informational purposes only A petition has been filed in federal court calling...
View ArticlePradaxa Bleeding Lawsuits Continue to Mount
As of June 2014, Saiontz & Kirk is no longer accepting new Pradaxa clients The contents of this page are provided for informational purposes only For nearly two years, the Pradaxa lawyers at...
View ArticleClik here to view.
Xarelto Lawyers Reviewing Cases Nationwide for Bleeding Injury, Wrongful Death
The product liability lawyers at Saiontz & Kirk, P.A. are now providing free consultations and claim evaluations for individuals and families throughout the United States who may be entitled to...
View ArticleClik here to view.
Xarelto Bleeding Risks Not Adequately Disclosed
In an effort to maximize profits from their new generation blood thinner Xarelto, Johnson & Johnson and Bayer appear to have caused thousands of unnecessary injuries and death by downplaying the...
View ArticleXarelto Reversal Agent Not Fully Researched Before Drug Introduced
Although Xarelto has been promoted as a superior alternative to warfarin (Coumadin), because it is easier to take and requires less monitoring during treatment, there is currently no Xarelto reversal...
View ArticleXarelto Class Action Lawsuit-Like Centralization for Bleeding Injury Cases in...
A motion has been filed in the federal court system, seeking to consolidated all Xarelto bleeding injury cases as part of an MDL, or Multidistrict Litigation. While such centralized pretrial...
View ArticleClik here to view.
Xarelto Blood Monitoring May Have Avoided Deaths, Hospitalizations
While Xarelto has been promoted as a superior alternative to warfarin, with the drug makers claiming that it is easier to use and does not require regular blood monitoring, there is increasing evidence...
View ArticleClik here to view.
Xarelto Injury Cases to be Transferred to MDL in Louisiana
With a growing number of Xarelto injury lawsuits continuing to be filed in U.S. District Courts throughout the country, a panel of federal judges has established a coordinated proceeding for the...
View ArticleClik here to view.
Despite Bleeding Problems, Xarelto Sales Continue to Help J&J Reap Huge Profits
Amid continuing concerns about the risk of uncontrollable bleeding on Xarelto and the lack of an approved reversal agent, Johnson & Johnson indicates that sales of their blockbuster anticoagulant...
View ArticleClik here to view.
Xarelto Internal Bleeding, Other Injury Lawsuits Moving Toward Trial
The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the U.S. who are pursuing a Xarelto lawsuit after experiencing internal bleeding, hemorrhaging or another bleeding injury caused...
View ArticleXarelto Complications and Injuries Stand Out Among FDA Adverse Event Reports...
As thousands of Xarelto injury lawsuits continue to move forward through the court system, a new report highlights the extent of severe problems and bleeding complications that have been linked to this...
View ArticleClass Action Lawsuit for Pradaxa vs MDL
A petition has been filed in federal court calling for the consolidation of all lawsuits over bleeding problems with Pradaxa as part of a multidistrict litigation, or MDL, where the cases would be...
View ArticleXarelto Lawyers Reviewing Cases Nationwide for Bleeding Injury, Wrongful Death
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only. The...
View ArticleXarelto Bleeding Risks Not Adequately Disclosed
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only. In...
View ArticleXarelto Reversal Agent Not Fully Researched Before Drug Introduced
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only....
View ArticleXarelto Class Action Lawsuit-Like Centralization for Bleeding Injury Cases in...
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only....
View ArticleXarelto Blood Monitoring May Have Avoided Deaths, Hospitalizations
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only....
View ArticleXarelto Injury Cases to be Transferred to MDL in Louisiana
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only....
View ArticleDespite Bleeding Problems, Xarelto Sales Continue to Help J&J Reap Huge Profits
UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only....
View Article
